MedTrace Logo

Comparison Study in Pancreatic Fiducial Placement

NCT02376543 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2020-09-29

No results posted yet for this study

Summary

Comparison Study between 19 gauge EUS FNA BNX Needle vs. 22 gauge EUS FNA BNX Needle in Pancreatic Fiducial Placement To Treat Pancreatic Cancer

Conditions

  • Pancreatic Neoplasms

Interventions

DEVICE

19 Gauge EUS FNA BNX

There will be fiducials placed in the pancreas according to facility policy and procedure utilizing the 19 gauge needle.

DEVICE

22 Gauge EUS FNA BNX

There will be fiducials placed in the pancreas according to facility policy and procedure utilizing the 22 gauge needle.

Sponsors & Collaborators

  • Parkview Health

    lead OTHER

Principal Investigators

  • Neil Sharma, MD · Parkview Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-06
Primary Completion
2019-03-15
Completion
2019-03-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02376543 on ClinicalTrials.gov